Skip to main content

Featured

Tech Stocks Lift Futures Ahead of Nvidia’s Earnings

U.S. stock futures edged higher as investors positioned themselves for one of the most closely watched earnings reports of the season: Nvidia’s. The Dow Jones Industrial Average, S&P 500, and Nasdaq 100 futures all posted early gains, reflecting renewed optimism in the tech sector. Market Mood Brightens Futures tied to the Dow showed modest strength, supported by cyclical stocks. The S&P 500 and Nasdaq futures climbed as traders bet on continued momentum in artificial intelligence–driven companies. Nvidia’s upcoming earnings report is widely expected to influence the broader market, given the company’s outsized role in the AI boom. Why Nvidia Matters Today Nvidia has become a bellwether for tech sentiment. Its performance often sets the tone for semiconductor stocks and, increasingly, the entire market. Investors are watching for: AI chip demand updates Revenue growth tied to data centers Forward guidance that could sway market direction A strong report could ...
Post a Comment
Read more

article

Labels

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Labels:

Comments

Post a Comment